Skip to main content
Clinical Trials/ACTRN12622000661774
ACTRN12622000661774
Completed
未知

Bedside Neuromodulation of Persistent Pain and Allodynia with Caloric Vestibular Stimulation: An Effectiveness Trial

Alfred Health0 sites38 target enrollmentMay 5, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Persistent pain
Sponsor
Alfred Health
Enrollment
38
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 5, 2022
End Date
November 29, 2013
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • (i) persistent pain (\>3 months) at or below deafferentation level for phantom limb pain and spinal cord injury pain;
  • (ii) persistent pain (\> 3months) in complex regional pain syndrome as diagnosed by treating pain clinician;
  • (iii) musculoskeletal persistent pain (\> 3 months) for non\-specific persistent pain patients.

Exclusion Criteria

  • (i) epilepsy or any brain disorder;
  • (ii) ear disease within the past five years;
  • (iii) pregnancy;
  • (iv) cardiac or respiratory disease (unless cleared by treating specialist);
  • (v) alcohol or substance dependence, or psychiatric comorbidity (except depression).
  • Absence of these conditions was confirmed via medical records and clinical interview.

Outcomes

Primary Outcomes

Not specified

Similar Trials